Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
紐約州塔裏敦，2024年7月2日（環球新聞專線）——Prestige Consumer Healthcare Inc.（紐約證券交易所代碼：PBH）今天宣佈，將在市場開盤前於2024年8月8日星期四發佈2025財年第一季度業績。該公司將在美國東部時間當天上午 8:30 舉行電話會議，討論結果。
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
要參加電話會議的互聯網直播，可以從的 “投資者關係” 頁面進行訪問。要通過電話參加電話會議，參與者可以在此處註冊電話以獲得撥入詳細信息和唯一的密碼。雖然不是必需的，但建議在活動開始前 10 分鐘加入。
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company's Investor Relations page.
電話會議重播將在直播結束後的大約一週內提供，可以在公司的投資者關係頁面上訪問。
About Prestige Consumer Healthcare Inc.
關於 Prestige 消費者醫療保健公司
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux's Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration products and the Fess line of nasal and sinus care products in Australia. Visit the Company's website at .
Prestige Consumer Healthcare向美國、加拿大、澳大利亞以及某些其他國際市場的零售店銷售、製造和分銷消費者保健產品。該公司的多元化品牌組合包括 Monistat 和 Summer's Eve 女性健康產品、BC 和 Goody's 止痛藥、Clear Eyes 和 TheraTears 眼部護理產品、DenTek 專業口腔護理產品、Dramamine 暈車療法、Fleet 灌腸劑和甘油栓劑、Chloraseptic 和 Luden's 喉嚨痛治療和滴劑、Compound W 疣治療、Little Remedies 兒科非處方藥產品、Boudreaux's Butt Paste 尿布疹軟膏、Nix 蝨子治療劑、Debrox 耳垢去除劑、加拿大的 Gaviscon 抗酸劑和 Hydralyte補液產品和澳大利亞的Fess鼻腔和鼻竇護理產品系列。訪問該公司的網站，網址爲。
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
投資者關係聯繫人
菲爾·特波利利，特許金融分析師，914-524-6819
irinquiries@prestigebrands.com
Source: Prestige Consumer Healthcare Inc.
資料來源：Prestige 消費者醫療保健公司
譯文內容由第三人軟體翻譯。